2024 Journal Article The clinical relevance of MOG antibody testing in cerebrospinal fluidReynolds, Molly, Tan, Irene, Nguyen, Kristy, Merheb, Vera, Lee, Fiona X. Z., Trewin, Benjamin P, Lerch, Magdalena, Shah, Snehal, Wolfe, Nigel, Buzzard, Katherine, Lechner-Scott, Jeannette, Fabis-Pedrini, Marzena, Fok, Anthony, John, Nevin, Kneebone, Chris, Yiannikas, Con, Brown, David A., Kermode, Allan G., Reddel, Stephen, Dale, Russell C., Brilot, Fabienne, Ramanathan, Sudarshini, Adam, Robert, Andersen, Jane, Andrews, Ian, Antony, Jayne, Aouad, Patrick, Badve, Monica, Barnett, Michael H. ... on behalf of the Australasian MOGAD Study Group (2024). The clinical relevance of MOG antibody testing in cerebrospinal fluid. Annals of Clinical and Translational Neurology, 11 (9), 1-6. doi: 10.1002/acn3.52163 |
2024 Journal Article Long-term efficacy and safety of Rituximab in the treatment of neuromyelitis optica spectrum disorderHayes, Michael Thomas Gerard, Adam, Robert J., McCombe, Pamela Ann, Walsh, Michael and Blum, Stefan (2024). Long-term efficacy and safety of Rituximab in the treatment of neuromyelitis optica spectrum disorder. Multiple Sclerosis Journal, 10 (2) 20552173241257876, 20552173241257876. doi: 10.1177/20552173241257876 |
2024 Journal Article Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programmeHardy, TA, Aouad, P, Barnett, MH, Blum, S, Broadley, S, Carroll, WM, Crimmins, D, Griffiths, D, Hodgkinson, S, Lechner-Scott, J, Lee, A, Malhotra, R, McCombe, P, Parratt, J, Plummer, C, Van der Walt, A, Martel, K and Walker, RA (2024). Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programme. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 10 (1) 20552173231226106. doi: 10.1177/20552173231226106 |
2023 Journal Article Phenotypic variability within the desminopathies: A case series of three patientsYeow, Dennis, Katz, Matthew, Henderson, Robert, Prasad, Sandhir, Denman, Russell, Blum, Stefan, Davis, Mark, Robertson, Thomas and McCombe, Pamela (2023). Phenotypic variability within the desminopathies: A case series of three patients. Frontiers in Neurology, 13 1110934. doi: 10.3389/fneur.2022.1110934 |
2022 Journal Article Neuroimaging characteristics may aid in diagnosis, subtyping, and prognosis in autoimmune encephalitisBroadley, James, Wesselingh, Robb, Beech, Paul, Seneviratne, Udaya, Kyndt, Chris, Buzzard, Katherine, Nesbitt, Cassie, D’Souza, Wendyl, Brodtmann, Amy, Macdonell, Richard, Kalincik, Tomas, O’Brien, Terence J., Butzkueven, Helmut, Monif, Mastura, Griffiths, Sarah, Rushen, Tiffany, Tan, Tracie, Malpas, Charles, Halliday, Amy, Alpitsis, Rubina, Seery, Nabil, Tarlinton, David, Reddel, Steve, Hardy, Todd, Taylor, Bruce, Long, Brian, Wijeratne, Tissa, White, Owen, Fielding, Jo ... Clough, Meaghan (2022). Neuroimaging characteristics may aid in diagnosis, subtyping, and prognosis in autoimmune encephalitis. Neurological Sciences, 44 (4), 1327-1340. doi: 10.1007/s10072-022-06523-9 |
2022 Journal Article Oral health‐related quality of life is more strongly correlated with mental health than with oral health in relapsing‐remitting multiple sclerosisNangle, Matthew R., Manchery, Nithin, Swayne, Andrew, Boocock, Helen, Blum, Stefan and Henry, Julie D. (2022). Oral health‐related quality of life is more strongly correlated with mental health than with oral health in relapsing‐remitting multiple sclerosis. Journal of Oral Rehabilitation, 50 (1), 62-68. doi: 10.1111/joor.13387 |
2022 Journal Article Psychiatric manifestations of autoimmune encephalitisFord, Hannah, Griffith, Sarah, Warren, Nicola, Swayne, Adrew, Blum, Stefan, Butzkueven, Helmut, O'Brien, Terence J., Velakoulis, Dennis, Kulkarni, Jayashri and Monif, Mastura (2022). Psychiatric manifestations of autoimmune encephalitis. Autoimmunity Reviews, 21 (9) 103145, 1-7. doi: 10.1016/j.autrev.2022.103145 |
2022 Conference Publication Novel generation of real-world evidence through MSGo, a digital support program supporting the use of siponimod in secondary progressive multiple sclerosis patients in AustraliaHardy, Todd, Aouad, Patrick, Blum, Stefan, Broadley, Simon, Carroll, William, Crimmins, Denis, Griffiths, Dayna, Hodgkinson, Suzanne, Lechner-Scott, Jeanette, Lee, Andrew, Malhotra, Ram, Parratt, John, Plummer, Chris, Walt, Anneke Van der and Walker, Robert (2022). Novel generation of real-world evidence through MSGo, a digital support program supporting the use of siponimod in secondary progressive multiple sclerosis patients in Australia. ANZAN Annual Scientific Meeting 2022, Melbourne, VIC Australia, 10-13 May 2022. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2022-anzan.64 |
2022 Journal Article Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational dataHardy, Todd A., Parratt, John, Beadnall, Heidi, Blum, Stefan, Macdonell, Richard, Beran, Roy G, Shuey, Neil, Lee, Andrew, Carroll, William, Shaw, Cameron, Worrell, Richard, Moody, Jana, Sedhom, Mamdouh, Barnett, Michael and Vucic, Steve (2022). Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data. BMJ Neurology Open, 4 (2) e000315, 1-9. doi: 10.1136/bmjno-2022-000315 |
2022 Journal Article Analysing triggers for anti‐NMDA‐receptor encephalitis including herpes simplex virus encephalitis and ovarian teratoma: results from the Queensland autoimmune encephalitis cohortSwayne, Andrew, Warren, Nicola, Prain, Kerri, Gillis, David, Wong, Richard and Blum, Stefan (2022). Analysing triggers for anti‐NMDA‐receptor encephalitis including herpes simplex virus encephalitis and ovarian teratoma: results from the Queensland autoimmune encephalitis cohort. Internal Medicine Journal, 52 (11), 1943-1949. doi: 10.1111/imj.15472 |
2022 Journal Article Anti-glutamic acid decarboxylase antibody screening in first-episode psychosisWarren, Nicola, Freier, Karen, Siskind, Dan, O’Gorman, Cullen, Blum, Stefan, Gillis, David and Scott, James G (2022). Anti-glutamic acid decarboxylase antibody screening in first-episode psychosis. Australian and New Zealand Journal of Psychiatry, 57 (4) 00048674221089560, 48674221089560-612. doi: 10.1177/00048674221089560 |
2022 Journal Article Episodic foresight in multiple sclerosisManchery, Nithin, Henry, Julie D., Blum, Stefan, Swayne, Andrew, Beer, Reuben, Rendell, Peter G. and Nangle, Matthew R. (2022). Episodic foresight in multiple sclerosis. Neuropsychology, 36 (2), 140-149. doi: 10.1037/neu0000785 |
2021 Journal Article Cognitive function and oral health in relapsing–remitting multiple sclerosisManchery, Nithin, Henry, Julie D., Swayne, Andrew, Beer, Reuben, Blum, Stefan and Nangle, Matthew R. (2021). Cognitive function and oral health in relapsing–remitting multiple sclerosis. Clinical Oral Investigations, 26 (3), 2899-2907. doi: 10.1007/s00784-021-04272-1 |
2021 Journal Article MRI patterns distinguish AQP4 antibody positive neuromyelitis optica spectrum disorder from multiple sclerosisClarke, Laura, Arnett, Simon, Bukhari, Wajih, Khalilidehkordi, Elham, Jimenez Sanchez, Sofia, O'Gorman, Cullen, Sun, Jing, Prain, Kerri M., Woodhall, Mark, Silvestrini, Roger, Bundell, Christine S., Abernethy, David A., Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brownlee, Wallace, Butzkueven, Helmut, Carroll, William M., Chen, Cella, Coulthard, Alan, Dale, Russell C., Das, Chandi, Fabis-Pedrini, Marzena J., Gillis, David, Hawke, Simon, Heard, Robert, Henderson, Andrew P. D. ... Broadley, Simon A. (2021). MRI patterns distinguish AQP4 antibody positive neuromyelitis optica spectrum disorder from multiple sclerosis. Frontiers in Neurology, 12 722237, 722237. doi: 10.3389/fneur.2021.722237 |
2021 Journal Article NMOSD and MS prevalence in the Indigenous populations of Australia and New ZealandBukhari, Wajih, Khalilidehkordi, Elham, Mason, Deborah F., Barnett, Michael H., Taylor, Bruce V., Fabis-Pedrini, Marzena, Kermode, Allan G., Subramanian, Sankar, Waters, Patrick, Broadley, Simon A., Bukhari, Wajih, Broadley, Simon A., Abernethy, David, Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brilot, Fabienne, Brownlee, Wallace J., Bundell, Christine S., Butzkueven, Helmut, Carroll, William M., Chen, Celia, Clarke, Laura, Coulthard, Alan, Dale, Russell C., Das, Chandi, Dear, Keith ... Yiu, Eppie M. (2021). NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand. Journal of Neurology, 269 (2), 836-845. doi: 10.1007/s00415-021-10665-9 |
2021 Conference Publication Case Series: Two Cases of First Presentation AQP4-IgG Antibody Positive Neuromyelitis Optica in Patients of Advanced Age as a Possible Paraneoplastic PhenomenonBeer, Reuben, Shahid, Hassan, Brown, Helen and Blum, Stefan (2021). Case Series: Two Cases of First Presentation AQP4-IgG Antibody Positive Neuromyelitis Optica in Patients of Advanced Age as a Possible Paraneoplastic Phenomenon. AAN 73rd Annual Meeting, Online, 17-22 April 2021. Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/wnl.96.15_supplement.2975 |
2021 Journal Article A case of Anti-LGi1 antibody positive autoimmune epilepsy following deep brain stimulator implantation for essential tremorBeer, Reuben, Lehn, Alex and Blum, Stefan (2021). A case of Anti-LGi1 antibody positive autoimmune epilepsy following deep brain stimulator implantation for essential tremor. Journal of Neuroimmunology, 353 577503, 1-2. doi: 10.1016/j.jneuroim.2021.577503 |
2021 Journal Article Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell TherapyIoannides, Zara A., Csurhes, Peter A., Douglas, Nanette L., Mackenroth, Gem, Swayne, Andrew, Thompson, Kate M., Hopkins, Tracey J., Green, Kerryn A., Blum, Stefan, Hooper, Kaye D., Wyssusek, Kerstin H., Coulthard, Alan and Pender, Michael P. (2021). Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy. Frontiers in Neurology, 12 652811, 652811. doi: 10.3389/fneur.2021.652811 |
2021 Journal Article A case of IVIg responsive paraneoplastic SOX1 peripheral neuropathy in a male with breast carcinomaBeer, Reuben, O'Gorman, Cullen, Horwood, Keith and Blum, Stefan (2021). A case of IVIg responsive paraneoplastic SOX1 peripheral neuropathy in a male with breast carcinoma. Journal of Neuroimmunology, 352 577492, 577492. doi: 10.1016/j.jneuroim.2021.577492 |
2021 Journal Article An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapySwayne, Andrew, Warren, Nicola, Prain, Kerri, Gillis, David, O'Gorman, Cullen, Tsang, Benjamin K-T., Muller, Claire, Broadley, Simon, Adam, Robert J., McCombe, Pamela, Wong, Richard C. and Blum, Stefan (2021). An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapy. Frontiers in Neurology, 12 607773, 607773. doi: 10.3389/fneur.2021.607773 |